Price · last 3 months · daily close
CBOE price
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
ValeriusBeta - Not investment advice
Research · S&P 500 · Financials
The numbers, the scorecard and what analysts say, with the source for each. Information, not advice.
Price · last 3 months · daily close
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
Value Scorecard · run 2026-10-18
Earnings & returns
Diluted EPS: $2.19 (2022), $7.13 (2023), $7.21 (2024), $10.42 (2025). It rose every year; the framework scores that as 5.
ROE (net income / common equity): 6.8% (2022), 19.0% (2023), 17.8% (2024), 21.3% (2025). Median 18.4%, lowest 6.8%; the framework scores a median 15-20% as 4.
ROIC of 21.1%: operating income of $1.47B divided by $6.94B of capital (total assets $9.31B minus current liabilities $2.36B), fiscal year to Dec 31, 2025, as filed in the 10-K (SEC EDGAR). The framework scores above 20% as 5.
Net margin of 26.7%; the framework scores above 20% as 5; gross margin 54.1%, operating margin 34.6%.
Balance sheet & cash
Net cash: total debt $1.58B, total cash $2.35B. The framework scores a net cash position as 5.
Free cash flow (operating cash flow minus capital expenditure): $591.30M (2022), $1.03B (2023), $1.04B (2024), $1.68B (2025). It rose every year; the framework scores that as 5.
Retained earnings, as filed in the 10-Ks (SEC EDGAR): $2.17B (2022), $2.53B (2023), $2.82B (2024), $3.54B (2025). It rose every year; the framework scores that as 5.
Valuation models
IV = EPS x (8.5 + 2g) x (4.4 / Y) = $12.83 x (8.5 + 2 x 20.0) x (4.4 / 4.5) = $608.43 (EPS CAGR 20.9% capped at 20%). Current price $314.98; price is 48.2% below the model value.
FCF/share = $6.495, stage 1 growth = 11.8% for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $34.10, PV of terminal value = $103.64, DCF value = $137.75. Current price $314.98; price is 128.7% above the model value.
Graham value $608.43 (price is 48.2% below the model value); DCF value $137.75 (price is 128.7% above the model value).
P/B of 5.85; the framework scores above 5.0 as 1.
Business quality
A moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.
Return on capital, each year
Above 15% in 4 of 10 years (2016-2025); lowest 7.5%, highest 77.1%.
Gross margin, each year
Between 44.7% and 84.6% over 3 years (a range of 39.9 points).
Competition, in the company’s own words · 10-K filed Feb 20, 2026
Cboe is a leading provider of market infrastructure and tradable products across cash and spot markets, derivatives markets, and Cboe Data Vantage products and services. Cboe delivers cutting-edge trading, clearing, and investment solutions across the globe through a comprehensive ecosystem that helps drive innovation and growth.
The opening of the company’s “Competitive Strengths” section in its 10-K, quoted word for word, not summarized or edited. It is the company’s own description, not Valerius’s view, and may include the company’s expectations. Open the filing.
Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.
Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $1.42B paid out against $4.34B of free cash flow (pass); total debt $1.87B to $1.59B, down 15.0%, 0.9x EBITDA (pass: not up more than 10%); shares outstanding 0.11B to 0.10B, down 1.2% (pass). 4 of 4 tests passed; the framework scores that as 5.
Filings
Three kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.
Loading...
These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.
Graham Formula:
IV = EPS x (8.5 + 2g) x (4.4 / Y)
EPS = $12.83, g = 20.0%, Y = 4.5
g capped at 20.0% (3-year EPS CAGR was 20.9%)
IV = $608.43
Current price $314.98 vs Graham value $608.43 — price is 48.2% below the model value.
DCF:
FCF/share = $6.495
Stage 1 growth = 11.8% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
Y1: $7.261 → PV $6.601
Y2: $8.118 → PV $6.709
Y3: $9.076 → PV $6.819
Y4: $10.147 → PV $6.930
Y5: $11.344 → PV $7.044
Stage 1 PV sum = $34.10
Terminal value at end of Y5 = $166.92
PV of terminal value = $103.64
DCF value = $137.75
Current price $314.98 vs DCF value $137.75 — price is 128.7% above the model value.Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $314.98. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.
Recent headlines · third-party publishers · not investment advice
The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.